 |
|
|
Jun '07 |
Sep '07 |
Dec '07 |
Mar '08 |
Jun '08 |
|
| Sales Turnover |
19.95 |
23.86 |
23.49 |
23.04 |
28.42 |
| Other Income |
-- |
0.02 |
0.01 |
-- |
-- |
| Total Income |
19.95 |
23.88 |
23.51 |
23.04 |
28.43 |
| Total Expenses |
17.47 |
20.80 |
21.08 |
22.90 |
24.57 |
| Operating Profit |
2.48 |
3.06 |
2.41 |
0.14 |
3.85 |
| Profit On Sale Of Assets |
-- |
-- |
-- |
-- |
-- |
| Profit On Sale Of Investments |
-- |
-- |
-- |
-- |
-- |
| Gain/Loss On Foreign Exchange |
-- |
-- |
-- |
-- |
-- |
| VRS Adjustment |
-- |
-- |
-- |
-- |
-- |
| Other Extraordinary Income/Expenses |
-- |
-- |
-- |
-- |
-- |
| Total Extraordinary Income/Expenses |
-- |
-- |
-- |
-- |
-- |
| Tax On Extraordinary Items |
-- |
-- |
-- |
-- |
-- |
| Net Extra Ordinary Income/Expenses |
-- |
-- |
-- |
-- |
-- |
| Gross Profit |
2.48 |
3.08 |
2.42 |
0.14 |
3.85 |
| Interest |
0.79 |
0.74 |
0.59 |
0.72 |
0.89 |
| PBDT |
1.70 |
2.35 |
1.83 |
-0.58 |
2.97 |
| Depreciation |
0.36 |
0.43 |
0.40 |
0.46 |
0.41 |
| Depreciation On Revaluation Of Assets |
-- |
-- |
-- |
-- |
-- |
| PBT |
1.34 |
1.92 |
1.43 |
-1.04 |
2.56 |
| Tax |
0.35 |
0.28 |
0.28 |
0.43 |
0.98 |
| Net Profit |
0.99 |
1.64 |
1.15 |
-1.47 |
1.58 |
| Prior Years Income/Expenses |
-- |
-- |
-- |
-- |
-- |
| Depreciation for Previous Years Written Back/ Provided |
-- |
-- |
-- |
-- |
-- |
| Dividend |
-- |
-- |
-- |
-- |
-- |
| Dividend Tax |
-- |
-- |
-- |
-- |
-- |
| Dividend (%) |
-- |
-- |
-- |
-- |
-- |
| Earnings Per Share |
0.94 |
1.57 |
1.10 |
-- |
1.51 |
| Book Value |
-- |
-- |
-- |
-- |
-- |
| Equity |
10.45 |
10.45 |
10.45 |
10.45 |
10.45 |
| Reserves |
-- |
-- |
-- |
-- |
-- |
| Face Value |
10.00 |
10.00 |
10.00 |
10.00 |
10.00 |
|
|
|
|
|
| BSE: 524824 |
NSE: BALPHARMA |
Reuters: BALP.BO N.A |
|
|
| Source : Asian CERC |
|
Online
